Sign in

You're signed outSign in or to get full access.

Michael Ozimek

Executive Vice President and Chief Financial Officer at TRUSTCO BANK CORP N Y
Executive

About Michael Ozimek

Executive Vice President and Chief Financial Officer of TrustCo Bank Corp NY and Trustco Bank since 2018; previously Senior Vice President and CFO from 2014–2018; executive officer since 2014; joined TrustCo in 2002. Age 51 as of March 24, 2025 . Company performance in 2024: Net Income $48.8 million, ROAA 0.80%, Diluted EPS $2.57, Efficiency Ratio 61.55%; TSR (value of $100) was 96.84 vs peer group 106.14 . Say‑on‑pay support improved to 87.22% at the 2024 Annual Meeting (vs 75.30% in 2023) following program changes .

Past Roles

OrganizationRoleYearsStrategic Impact
TrustCo Bank Corp NY / Trustco BankEVP & CFO2018–presentFinance leadership through rate cycle; emphasis on underwriting and efficiency supporting ROAA and EPS outcomes .
TrustCo Bank Corp NY / Trustco BankSVP & CFO2014–2018Led finance during expansion; elevated to EVP reflecting broader scope .
TrustCo Bank Corp NY / Trustco BankJoined company2002–presentLong-tenured internal leader; continuity across cycles .

External Roles

No external directorships or outside roles disclosed for Ozimek in the proxy .

Fixed Compensation

Base Salary (multi-year)

Metric202220232024
Base Salary ($)$417,500 $431,442 $415,000
Metric2025
Base Salary ($) (effective for 2025)$431,600

Perquisites and Other Compensation (2024)

Component2024 Amount ($)Notes
All Other Compensation (total)$536,647 Includes items below.
Tax gross‑ups on personal benefits$24,144 Gross‑ups on taxable perqs.
401(k)/Profit Sharing match$15,525 Company match.
Cash paid in lieu of frozen SERP (recognized in 2024 “all other”)$471,848 In lieu of SERP accruals.
Cash paid in Jan 2025 in lieu of SERP (for 2024 plan year)$479,106 Payment timing disclosure.
Other perqs (auto, health insurance, tax planning, club)Included (amounts not itemized) Provided to all NEOs.

Performance Compensation

Annual Executive Officer Incentive Plan (EOIP) – 2024 outcomes

MetricWeightThresholdTargetSuperior2024 ActualPayout Component
Return on Average Assets (ROAA)25% 0.85% 0.95% 1.05% 0.80% 0% (not achieved)
Adjusted Efficiency Ratio25% 59.50% 57.00% 54.50% 61.55% 0% (not achieved)
Diluted EPS25% $2.90 $3.15 $3.40 $2.57 0% (not achieved)
Net charge‑offs / Avg loans25% 0.15% 0.10% 0.05% <0.05% (Superior) Max for this metric
EOIP Payout to OzimekValue
% of base salary18.75%
Cash paid (2025 for 2024 plan)$77,813

Long‑Term Incentive (2019 Equity Incentive Plan)

Grant DateInstrumentUnits (Target)Grant‑Date Fair Value ($)VestingSettlement
11/19/2024PSUs4,124 $149,990 3‑year performance period (financial metrics) Shares (equity)
11/19/2024RSUs (time‑based)2,750 $100,018 Time‑based RSUs granted; schedule not specified in footnote (6) Shares
11/21/2023RSUs (time‑based)2,215 Vest in equal annual installments on 2nd & 3rd anniversary Shares
11/15/2022RSUs877 (unvested portion) Vest in full Nov 2025; cash‑settled Cash
11/15/2022PSUs (outstanding)5,916 (max assumption) 3‑year period to Nov 2025; cash‑settled if goals achieved Cash

Allocation: PSU weight 60% and RSU weight 40% of annual LTI value for NEOs in 2024 . Company stopped granting options (none since 2015) and does not grant option‑like instruments .

Equity Ownership & Alignment

Beneficial Ownership (as of Dec 31, 2024)

HolderShares% of Class
Michael M. Ozimek28,596 * (<1%)

Outstanding Equity Awards (as of Dec 31, 2024)

AwardGrant DateUnvested/Unearned Units (#)Market Value ($)
RSUs (cash‑settled)11/15/2022877 $29,213
PSUs (cash‑settled; max assumption)11/15/20225,916 $197,062
RSUs (stock‑settled)11/21/20232,215 $73,782
PSUs (stock‑settled; max assumption)11/21/20234,984 $166,017
RSUs (stock‑settled)11/19/20242,750 $91,603
PSUs (stock‑settled; max assumption)11/19/20244,124 $137,370

Ownership guidelines: EVPs must hold stock equal in value to 2× base salary; compliance achieved by Ozimek as of Dec 31, 2024 . Hedging and pledging of Company securities are prohibited for executives .

Employment Terms

Change‑in‑control/severance: If terminated by Company without good cause or by executive for good reason within 12 months prior to, or within two years following, a change in control, Ozimek receives 2.99× then‑current annual compensation paid in a lump sum within 10 days; no excise tax gross‑up applies to Ozimek (gross‑up applies only to CEO) . Definitions of change‑in‑control follow IRC §409A; medical reimbursement, transfer of company car and club membership apply in specified CIC terminations .

Potential Payments (as of Dec 31, 2024)

ScenarioSalary+Bonus ($)Health & Perqs ($)Pension ($)Equity Incentives ($)Total ($)
Termination by Company Without Good Cause; no CIC964,661 892,954 22,525 1,880,140
Retirement; no CIC22,525 186,714 1,102,193
Disability892,954 22,525 381,313 1,296,792
Death600,000 892,954 22,525 381,313 1,896,792
Change in Control or Termination in connection with CIC1,473,511 942,954 22,525 381,313 2,820,303

Clawback: Robust clawback policy covering executive incentive awards for material restatement or fraud/misconduct; meets Nasdaq Listing Rule 5608 .

Performance & Track Record (Company snapshot during tenure)

Metric202220232024
Net Income ($mm)75.2 58.6 48.8
ROAA (%)1.22 0.97 0.80
Diluted EPS ($)3.93 3.08 2.57

TSR (value of $100 initial investment): Company 96.84; peer group 106.14 for 2024 .

Compensation Structure Analysis

  • Shift to equity settlement for LTI awards beginning Nov 2023 and continued in 2024; PSUs now settled in shares; RSUs stock‑settled (earlier awards were cash‑settled) .
  • LTI weighting skewed to performance: PSUs 60% vs RSUs 40% of annual LTI value for NEOs .
  • No stock options since 2015; company does not grant option‑like instruments, reducing potential for option repricing risk .
  • SERP frozen since 2008; executives receive direct cash payments in lieu of SERP accruals (e.g., Ozimek $471,848 reflected in 2024 compensation; $479,106 paid in Jan 2025); benefit to be discontinued for new executives effective Dec 2024, addressing investor feedback .
  • No excise tax gross‑up in Ozimek’s employment agreement; CIC equity awards no single‑trigger acceleration under current program .

Equity Ownership & Insider Selling Pressure

  • Upcoming vesting: 2022 RSUs vest Nov 2025 (877 units; cash‑settled) ; 2023 RSUs vest in equal annual tranches on the 2nd and 3rd anniversaries (2025 & 2026) ; 2022 PSUs performance period ends in 2025 with cash settlement if goals met . Hedging and pledging prohibited, moderating forced‑sale risk .

Say‑on‑Pay & Shareholder Feedback

  • 2024 Say‑on‑pay approval: 87.22% vs 75.30% in 2023; changes included heavier performance linkage and equity settlement; ongoing shareholder engagement with top holders .

Investment Implications

  • Alignment: Ozimek meets 2× salary ownership guideline; LTI is majority performance‑based with PSU equity settlement; hedging/pledging prohibited—positive alignment signals .
  • Retention: Strong CIC protection (2.99× annual compensation; medical/perq continuation) reduces departure risk but raises takeover costs; no excise tax gross‑up mitigates shareholder concern .
  • Near‑term selling pressure: 2025 vest events (RSUs and 2022 PSU/RSU maturities) could create trading windows; however, policies require retention until ownership thresholds are met, and hedging/pledging are barred .
  • Performance sensitivity: 2024 EOIP paid solely on superior credit quality (net charge‑offs), with ROAA/EPS/efficiency below targets; reinforces incentive focus on credit discipline and cost control, but indicates pay will compress in weaker years, aligning downside for cash incentives .